Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG)

C.J.A. Punt, J. Tol, C. J. Rodenburg, A. Cats, G-J. Creemers

DOI: 10.1200/jco.2008.26.15_suppl.lba4011

Journal of Clinical Oncology

Data up to Jan 2025

Published2008

Citations132

References0

Fields

Medicine Internal medicine Oncology Gastroenterology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without… (2008) – Journal of Clinical Oncology | Metascience Observatory Explorer